US Blood Culture Tests Market (2026-2031)
The US Blood Culture Tests Market was valued at $2045.4 Million in 2026 and projected to reach to $2868.8 Million by 2031, representing a compound annual growth rate of 7.0%. The US blood culture tests market is positioned for sustained expansion through 2031, driven by escalating hospital-acquired infection rates and heightened clinical emphasis on rapid sepsis diagnosis.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
US Blood Culture Tests Market Trends and Insights
- This growth trajectory reflects the US healthcare system's increasing emphasis on rapid sepsis diagnosis and infection management, driven by rising hospital-acquired infection rates and heightened clinical awareness.
- The US market benefits from advanced laboratory infrastructure, widespread adoption of automated culture systems, and strong reimbursement frameworks that support diagnostic testing. In the US, blood culture testing remains a critical component of infectious disease diagnostics, particularly in emergency departments and intensive care units.
- The forecast period through 2031 anticipates sustained demand across US healthcare facilities as clinicians prioritize early pathogen identification and antimicrobial stewardship.
- US laboratories are increasingly integrating molecular and rapid culture technologies to reduce time-to-result, enhancing patient outcomes and operational efficiency.
- Market expansion in the US is supported by ongoing investments in diagnostic infrastructure and the growing prevalence of bloodstream infections across diverse patient populations..
Key Market Statistics
- CAGR (2026-2031) 7.0% CAGR
- Market Size, 2026 ~USD 2045.4 Million
- Forecast, 2031 ~USD 2868.8 Million
- Country US
US Blood Culture Tests Market Overview
Market Valuation :
The US blood culture tests market is valued at $2,045.4 million in 2026 and is projected to reach $2,868.8 million by 2031, demonstrating strong growth momentum in the American healthcare sector.
Robust Growth Rate :
The US market is expanding at a 7.0% CAGR, outpacing the global average of 6.1%, indicating accelerated adoption of blood culture testing technologies across American healthcare institutions.
Sepsis Management Focus :
Rising hospital-acquired infection rates and increased clinical awareness of rapid sepsis diagnosis are driving demand for advanced blood culture testing solutions throughout US hospitals and diagnostic centers.
Healthcare System Emphasis :
The US healthcare system's growing prioritization of infection management and early detection protocols is creating sustained demand for reliable and rapid blood culture diagnostic solutions.
US Blood Culture Tests Market Dynamics
- Healthcare providers across the nation are increasingly investing in advanced diagnostic technologies to improve patient outcomes and reduce mortality associated with bloodstream infections.
- The market's 7.0% CAGR reflects strong institutional adoption and reimbursement support for blood culture testing.
- Technological innovations in automation and faster turnaround times are expected to further accelerate market penetration across US hospitals, diagnostic laboratories, and point-of-care settings, solidifying the sector's growth trajectory..
Market Ecosystem
BLOOD CULTURE TESTS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Provides BD BACTEC automated blood culture systems and culture media/bottles for detecting bacterial and fungal bloodstream infections across hospital and clinical microbiology laboratories | Enables continuous automated monitoring | Supports earlier detection of microbial growth | Improves laboratory workflow efficiency | Supports pathogen identification and subsequent AST workflows |
 |
Provides BACT/ALERT blood culture systems and culture bottles for automated detection of bloodstream infections, complemented by microbial identification and antimicrobial susceptibility testing solutions | Enables automated detection of bloodstream pathogens | Supports integrated microbiology workflows | Facilitates faster organism identification and susceptibility testing | Supports antimicrobial stewardship |
 |
Provides Oxoid blood culture and microbiology solutions, including culture media and related products used for cultivation, isolation, and subsequent characterization of microorganisms associated with bloodstream infections | Supports recovery and isolation of bloodstream pathogens | Provides broad microbiology workflow support | Enables downstream microbial identification and susceptibility testing | Supports routine clinical laboratory testing |
 |
Provides molecular diagnostic solutions through Luminex technology, including multiplex assays that can support rapid identification of pathogens and resistance markers associated with bloodstream infections, including testing from positive blood cultures where applicable | Accelerates pathogen identification | Enables multiplex detection of clinically relevant targets | Supports earlier treatment optimization | Complements conventional culture-based workflows |
 |
Through Beckman Coulter Diagnostics, provides microbiology solutions supporting microbial identification and antimicrobial susceptibility testing, complementing blood culture workflows after microbial growth is detected | Supports identification of bloodstream isolates | Enables antimicrobial susceptibility assessment | Improves laboratory workflow efficiency | Supports targeted antimicrobial treatment decisions |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Key Takeaways
- The US blood culture tests market will grow from $2,045.4M (2026) to $2,868.8M (2031) at a 7.0% CAGR.
- US healthcare facilities are adopting rapid and molecular culture technologies to accelerate pathogen identification and improve sepsis outcomes.
- Strong reimbursement policies and advanced laboratory infrastructure in the US support sustained market expansion through 2031.
- Rising hospital-acquired infection rates and antimicrobial stewardship initiatives are key drivers of US blood culture test demand.
Blood Culture Tests Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | REFERENCE LABORATORIES (End User) |
| Forecast Period | 2026-2031 |
| Growth Rate | CAGR of 6.1% from 2026 to 2031 |
| Largest Segment | BACTEREMIA (Application) |
| Market Size Base Year (Billions) | ~USD 6.65 (2026) |
| Revenue Forecast (Billions) | ~USD 8.94 (2031) |
| Segments Covered | Offering, Type, Method, Technology, Application, End User |
US Blood Culture Tests Market Report Segmentation
6 segment dimensions are covered across the global market.
By Offering
- Consumables
- Instruments
- Software & Services
By Type
- Aerobic Blood Culture Media
- Anaerobic Blood Culture Media
- Assay Kits & Reagents
- Automated Blood Culture Systems
- Blood Culture Accessories
- Blood Culture Media
- Colony Counters
- Fungi/Yeast Blood Culture Media
- Gram Stainers
- Incubators
- Microarrays
- Microscopes
- Mycobacterial Blood Culture Media
- Other Supporting Equipment
- Pcr
- Pediatric Aerobic Blood Culture Media
- Pna-Fish
- Supporting Laboratory Equipment
By Method
- Automated Blood Cultures
- Conventional/Manual Blood Cultures
By Technology
- Culture-Based Technologies
- Molecular Technologies
- Other Technologies
By Application
- Bacteremia
- Fungemia
- Mycobacterial Detection
By End User
- Academic & Research Laboratories
- Hospital Laboratories
- Other End Users
- Reference Laboratories
Target Audience
- In Vitro Diagnostics Manufacturers : Manufacturers need US market data to develop targeted product strategies, identify growth opportunities, and benchmark competitive positioning in the high-growth American blood culture testing sector.
- Hospital & Laboratory Administrators : Healthcare facility leaders require market insights to justify capital investments in blood culture testing infrastructure, evaluate vendor solutions, and optimize diagnostic protocols.
- Medical Device Investors : Investment firms and venture capitalists need comprehensive US market analysis to identify promising companies, assess market potential, and make informed funding decisions.
- Clinical Microbiology Professionals : Laboratory directors and microbiologists need market intelligence to stay informed about technological advances, best practices, and emerging diagnostic solutions in US healthcare.
- Healthcare Consultants & Analysts : Consulting firms and research analysts require detailed US market data to support client advisory services, competitive analysis, and strategic healthcare industry recommendations.
Reasons to Buy this Report
- Market Size & Growth Data : Access precise US market valuations ($2,045.4M in 2026 to $2,868.8M in 2031) with detailed 7.0% CAGR analysis to support strategic planning and investment decisions.
- Competitive Landscape Intelligence : Understand the US-specific competitive dynamics, market share distribution, and key player strategies within the American blood culture testing sector.
- Regulatory & Reimbursement Insights : Gain comprehensive knowledge of US FDA regulations, Medicare/Medicaid reimbursement policies, and healthcare compliance requirements affecting blood culture test adoption.
- Hospital & Laboratory Demand Analysis : Identify specific demand drivers across US hospitals, diagnostic laboratories, and clinical settings to optimize product positioning and market entry strategies.
- Technology & Innovation Trends : Discover emerging automation technologies, faster diagnostic methods, and point-of-care innovations shaping the future of blood culture testing in American healthcare.
Frequently asked questions
What is the current size of the US blood culture tests market?
The US blood culture tests market is estimated at $2,045.4 million in 2026.
What is the projected size of the US blood culture tests market by 2031?
The US blood culture tests market is forecast to reach $2,868.8 million by 2031.
What is the CAGR for the US blood culture tests market?
The US blood culture tests market is expected to grow at a compound annual growth rate of 7.0% from 2026 to 2031.
What factors are driving growth in the US blood culture tests market?
Key drivers include rising hospital-acquired infection rates, increased sepsis awareness, adoption of rapid diagnostic technologies, and strong reimbursement frameworks in the US healthcare system.
Which US healthcare settings have the highest demand for blood culture tests?
Emergency departments, intensive care units, and acute care hospitals in the US represent the largest demand segments for blood culture testing.
RESEARCH METHODOLOGY
The objective of this study is to analyze key market dynamics, including drivers, opportunities, restraints, and challenges, as well as the strategies of major players. It aims to monitor developments across leading players, including acquisitions, product launches, expansions, agreements, and partnerships. Additionally, the study will examine the competitive landscape of the blood culture tests market by evaluating market participants based on various criteria within the overarching categories of business and product strategy. To estimate the market size, both top-down and bottom-up approaches were employed. The market breakdown and data triangulation methods were used to assess segment and subsegment sizes.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases, and investor presentations of companies; white papers; certified publications; articles by recognized authors; gold- and silver-standard websites; regulatory bodies; and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
In the primary research process, various sources from the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were industry experts from core and related industries, as well as preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.
Note: C-level executives include Chief Executive Officers (CEOs), Chief Financial Officers (CFOs), Chief Operating Officers (COOs), and Vice Presidents (VPs).
Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Companies are classified into tiers based on their total revenue as of 2025. The tiers are as follows: Tier 1 = >USD 10 billion, Tier 2 = USD 1 billion to USD 10 billion, and Tier 3 = <USD 1 billion.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
For the global market value, annual revenue figures were calculated using revenue mapping for major product manufacturers and OEMs active in the global blood culture tests market. All major product manufacturers were identified at the global and/or country-/regional level. Revenue mapping for the respective business segments/subsegments was done for the major players. Additionally, the global market was split into various segments and subsegments:
- List of major players in the product market by region or country
- Product mapping of various blood culture product manufacturers at the regional and/or country level
- Mapping of annual revenue generated by listed major players from blood culture test products (or the nearest reported business unit/product category)
- Extrapolation of the revenue mapping of the listed major players to derive the global market size of the respective business segments, in terms of value
- Summation of revenue of all companies to arrive at the global blood culture tests market size
The data mentioned above was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.
Data Triangulation
After determining the overall size of the global blood culture tests market using the methodology described above, the market was segmented into several segments and subsegments. The data triangulation and market breakdown procedures were employed, as applicable, to complete the overall market engineering process and obtain exact market value data for the key segments and subsegments. The extrapolated market-related data was triangulated by studying various macro indicators and regional trends from demand- and supply-side participants.
Market Definition
Blood culture testing detects the presence of microbes such as bacteria, yeast, and other microorganisms in a blood specimen. This type of testing determines the nature and severity of blood infections, identifies the causative organisms of blood infections, and helps prevent adverse consequences.
Key Stakeholders
- Molecular diagnostics companies
- Clinical microbiology instrument and consumable manufacturers
- Research and consulting firms
- Clinical diagnostic laboratories
- Healthcare institutions (hospitals, medical schools, group practices, individual surgeons, and
- governing bodies)
- Medical device vendors/service providers
- Research institutes
- Venture capitalists and investors
Report Objectives
- To describe, segment, and forecast the blood culture tests market, by product, method, technology, application, and end user, in terms of value
- To forecast the size of the blood culture tests market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa, in terms of value
- To provide detailed information about the factors (drivers, restraints, opportunities, and challenges) influencing market growth
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall blood culture tests market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To profile the key players in the blood culture tests market and comprehensively analyze their core competencies and market shares
- To analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, partnerships, and R&D activities of the leading players in the market
- To benchmark players within the blood culture tests market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
Available customizations:
Based on the given market data, MarketsandMarkets offers customizations tailored to your company’s specific needs. The following customization options are available for the report:
GEOGRAPHIC ANALYSIS
- Further breakdown of the Rest of European blood culture tests market into Russia, Switzerland, Denmark, Austria, and others
- Further breakdown of the Rest of Asia Pacific blood culture tests market into Hong Kong, Taiwan, and others
- Further breakdown of the Rest of Latin American blood culture tests market into Argentina, Colombia, Chile, Ecuador, and others
- Further breakdown of the Southeast Asian blood culture tests market into Malaysia, Singapore, Australia, New Zealand, and others
COMPETITIVE LANDSCAPE ASSESSMENT
- Market Share Analysis, by region (North America and Europe), which provides the details about the share of the top 3 to 5 key players in the blood culture tests market
- Competitive leadership mapping for established players in the US
Get the Full Blood Culture Tests Market Report
Full forecast, segment splits, and company analysis for all Blood Culture Tests Market.
- Canada Blood Culture Tests Market
- Germany Blood Culture Tests Market
- UK Blood Culture Tests Market
- France Blood Culture Tests Market
- Italy Blood Culture Tests Market
- Spain Blood Culture Tests Market
- China Blood Culture Tests Market
- Japan Blood Culture Tests Market
- India Blood Culture Tests Market
- Brazil Blood Culture Tests Market
- Mexico Blood Culture Tests Market
- Rest Of Europe Blood Culture Tests Market
- Rest Of Asia Pacific Blood Culture Tests Market
- Rest Of Latin America Blood Culture Tests Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
